News & Events

Upcoming Events

Tue, 5/24/2022 - 12:00 PM ET
For patients/survivors - Join us every Tuesday for this general… more
Thu, 5/26/2022 - 8:00 PM CT
For caregivers, family & friends - You don’t need to take on… more
Fri, 5/27/2022 - 6:30 PM
For patients/survivors - General meetup moderated by survivors After… more
Tue, 5/31/2022 - 12:00 PM ET
For patients/survivors - Join us every Tuesday for this general… more
May 17, 2022

Newly Diagnosed with KRAS-Positive Lung Cancer?

May 17, 2022

Newly Diagnosed with KRAS-Positive Lung Cancer?

LUNGevity's Amy Moore, PhD, sits down with Mark Awad, MD, PhD, a thoracic oncologist at Dana-Farber Cancer Institute, to discuss KRAS-positive lung cancer and what questions newly diagnosed patients should ask their doctors. We discuss first-line treatment, biomarker testing, clinical trials, and drug resistance.
May 17, 2022

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma

May 17, 2022

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma

May 17, 2022

Broader Testing Options Pave the Way for Increasingly Tailored Lung Cancer Treatments

May 17, 2022

Broader Testing Options Pave the Way for Increasingly Tailored Lung Cancer Treatments

May 9, 2022

All Things KRAS: A Conversation with Terri Conneran and Dr. Darryl McConnell

May 9, 2022

All Things KRAS: A Conversation with Terri Conneran and Dr. Darryl McConnell

On January 31, 2022,  Amy Moore, PhD, brought us an update on KRAS. Dr. Moore, LUNGevity's Vice President of Global Engagement and Patient Partnerships, spoke with Terri Conneran, KRAS lung cancer survivor and founder of the KRAS Kickers; and Darryl McConnell, PhD, Research Site Head at Boehringer Ingelheim in Vienna, Austria.
May 9, 2022

Tracing Tumor Evolution Through Single-Cell Changes Could Provide Therapeutic Windows

May 9, 2022

Tracing Tumor Evolution Through Single-Cell Changes Could Provide Therapeutic Windows

May 9, 2022

A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients

May 9, 2022

A Novel Immune-Prognosis Index Predicts the Benefit of Lung Adenocarcinoma Patients

May 2, 2022

Tips for Better Sleep

May 2, 2022

Tips for Better Sleep

Sleep tips session with our sleep expert, Peggy Burhenn.
May 2, 2022

Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer

May 2, 2022

Glutaminase inhibition impairs CD8 T cell activation in STK11-/Lkb1-deficient lung cancer

May 2, 2022

Sotorasib Provides Durable Clinical Benefit for Patients wit

May 2, 2022

Sotorasib Provides Durable Clinical Benefit for Patients wit

May 1, 2022

Review Outlines Advancements in Precision Therapy for Metastatic Lung Cancer

May 1, 2022

Review Outlines Advancements in Precision Therapy for Metastatic Lung Cancer